A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC)

NCT01401985 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

95

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid Induced Constipation

Interventions

DRUG: TD-1211
DRUG: Placebo

Sponsor

Theravance Biopharma